Answers are grounded in this paper and cite their sources.
Objectives: Patent foramen ovale (PFO) has been implicated in cryptogenic stroke, transient ischemic attacks, migraine with auras, decompression sickness and severe refractory hypoxemia. Recently published data provided sufficient evidence for the percutaneous closure of PFO in the embolic stroke of an undetermined source. After a suspicion for a paradoxical cerebral embolism, a transthoracic echocardiography, transcranial doppler study, and transesophageal echocardiography using contrast bubble injection are indicated. Detection of PFO is possible during contrast bubble injection with or without Valsalva maneuver in transesophageal echocardiography. Three-or two-dimensional transesophageal echocardiography (TEE) give opportunity to obtain detailed information about complex anatomical variations in PFO morphologies including atrial septal aneurysm, large tunnel, increased height of PFO, lipomatous hypertrophy. Ideal device selection is important for the appropriate closure of PFO. A standardized classification is needed to define PFO morphologies when selecting the device size. In our study, we aimed to create a common language for different and high-risk morphologies with two-dimensional (2D) and three-dimensional (3D) TEE in patients with cryptogenic stroke that would be helpful in transcatheter PFO closure.
No takes yet. Share an insight, caveat, or question.
Sayın et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: